$1.69
0.00450.27%
Pre-Market: 4:31 PM EDT
Comments
Loading...
Innate Pharma (IPHA) Forecast
NewsEarningsInnate Pharma (IPHA) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestInnate Pharma (NASDAQ:IPHA) Stock Quotes, Forecast and News Summary
Innate Pharma Stock (NASDAQ: IPHA) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Innate Pharma (IPHA) stock?
You can purchase shares of Innate Pharma (NASDAQ:IPHA) through any online brokerage.
Who are Innate Pharma (IPHA) competitors?
Other companies in Innate Pharma’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Skye Bioscience (NASDAQ:SKYE), Adverum Biotechnologies (NASDAQ:ADVM), Atossa Therapeutics (NASDAQ:ATOS) and PepGen (NASDAQ:PEPG).
What is the forecast, or price target, for Innate Pharma (IPHA) stock?
Innate Pharma has a consensus price target of $10.83.
What is the current price for Innate Pharma (IPHA)?
The stock price for Innate Pharma (NASDAQ: IPHA) is $1.69 last updated November 20, 2024 at 4:31 PM EST.
Does Innate Pharma (IPHA) pay a dividend?
There are no upcoming dividends for Innate Pharma.
When is Innate Pharma (NASDAQ:IPHA) reporting earnings?
Innate Pharma’s H1 earnings are confirmed for Thursday, September 12, 2024.
Is Innate Pharma (IPHA) going to split?
There is no upcoming split for Innate Pharma.
What sector and industry does Innate Pharma (IPHA) operate in?
Innate Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.